Bod Science Limited
BOD.AX
Australian Securities Exchange0.02
AUD
- -
- -
Bod Science Limited
BOD.AX
(Australian Securities Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Bod Science Limited is an Australian healthcare company specializing in cannabis-focused drug development and cannabidiol (CBD) product innovation. Founded in 2016 and headquartered in Double Bay, New South Wales, the company develops, manufactures, and distributes cannabis-derived health, skincare, and wellness products. Its core offerings include pharmaceutical-grade medicinal cannabis products such as oils, capsules, oromucosal sprays, lozenges, creams, and proprietary delivery technologies like Aqua Phase to enhance bioavailability. Bod Science serves both medical and consumer markets, operating primarily in Australia with segments extending to the United Kingdom, Europe, and the United States. The company’s product categories cover medical therapeutic cannabis, over-the-counter CBD and hemp products, and herbal wellness items. In recent developments, Bod Science has engaged in strategic partnerships, notably with dsm-firmenich, to advance cannabinoid research and commercialization efforts. This collaboration supports the development of a GMP-certified CBD active pharmaceutical ingredient integral to the company’s clinical trial programs, including Phase IIb studies targeting conditions such as insomnia and anxiety. The company continues to emphasize a rigorous clinical trial pathway to bring scientifically validated, patent-protected cannabinoid therapeutics and health products to market. However, Bod Science was recently delisted from the Australian Securities Exchange following a prolonged suspension of its securities. Despite this, it maintains ongoing research and product innovation commitments, focusing on premium cannabis-derived formulations with enhanced absorption characteristics. Bod Science’s business model integrates research and development with commercial production, emphasizing Good Manufacturing Practice (GMP) standards to ensure quality and consistency across its product lines. The company targets healthcare providers, pharmacies, spas, department stores, and consumers seeking natural and scientific cannabis-based health solutions. Its operations are supported by collaborations with leading research organizations and corporate entities globally, underscoring its position in the medicinal cannabis and wellness industry. Bod Science continues to pursue growth through clinical validation and innovative product delivery technologies aimed at transforming the cannabis-based health and skincare markets.